For decades, the agency has redacted drug names from reports. Now, several former officials support ending the practice.

Having seen Congress spend money to onshore semiconductor production, pharma groups are pushing for similar incentives for ...

Last year, these treatments accounted for 75% of the $236B in annual sales set to vanish with the loss of exclusivity.

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative ...

President Donald Trump’s top health advisers announced a push to cut health costs by bringing more cutting-edge generic drugs ...

Artificial Intelligence–Based Digital Histologic Classifier for Prostate Cancer Risk Stratification: Independent Blinded Validation in Patients Treated With Radical Prostatectomy This study evaluated ...

A trade group representing generic drugmakers is seeking an injunction to thwart a provision of a new Connecticut law that places a price cap on ...

A proposed move by the US Food and Drug Administration (FDA) to accelerate development and ease approval of biosimilars could ...

Study breaks down high U.S. drug pricing. — -- High prescription drug prices in the United States are largely due to drug monopolies and restrictions on price negotiations, according to a new ...